PRFX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (1 Jun 2024 @ 04:00):

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel...

Stats
今日成交量	11 972.00
平均成交量	149 474
市值	1.76M
EPS	$0 ( 2024-05-15 )
下一个收益日期	( $-1.040 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00900 (1.27%)

PainReform Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PainReform Ltd. 财务报表

Annual	2023
营收:	$0
毛利润:	$-15 000.00 (0.00 %)
EPS:	$-7.14

FY	2023
营收:	$0
毛利润:	$-15 000.00 (0.00 %)
EPS:	$-7.14

FY	2022
营收:	$86 000.00
毛利润:	$71 000.00 (82.56 %)
EPS:	$-8.25

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.720

Financial Reports:

No articles found.

PainReform Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PainReform Ltd.

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.